Reach Us +1-218-451-2974


Editor - Suzanne de la Monte | Department of Pathology and Medic | 2154
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 2275

Journal of Alzheimers Disease & Parkinsonism received 2275 citations as per google scholar report

Journal of Alzheimers Disease & Parkinsonism peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Suzanne de la Monte

Suzanne de la Monte
Suzanne de la Monte
Associate Professor
Department of Pathology and Medicine
Pierre Galletti Laboratories
Tel: 401-444-7441
Fax: 401-444-2939


Suzanne de la Monte is a physician scientist who directs basic and translational research in the laboratory. I also perform clinical service work in Neuropathology. This activity includes teaching residents and students. Her research efforts are mainly focused on understanding the role of insulin and insulin-like growth factor resistance in relation to neurodegeneration caused by Alzheimer′s disease and chronic alcohol abuse.

Research Interest

Suzanne is interested in the molecular mechanisms of programmed cell death as well as the role of aspartyl (asparaginyl) beta hydroxylase (AAH) in cell motility and invasiveness of tumor cells as well as neuronal cells. In addition, the studies focus on growth factor signaling through IRS 1 and the role of this pathway in oncogenesis.